PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Human Cell1 citations

Chebulagic acid targets FBXO38 to enhance natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma

View Full Paper
XHXiaozhou HuRSRui ShaLZLei Zhang

Key Points

  • Chebulagic acid enhances natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma.
  • The expression of FBXO38 is a significant factor in this immune response.
  • Assessment of immune markers demonstrates improved efficacy against tumors when treated with chebulagic acid.
  • Further clinical research is warranted to evaluate the therapeutic potential of chebulagic acid in cancer treatment.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hu et al. (2026) studied this question.

synapsesocial.com/papers/69a759f9c6e9836116a1f695https://doi.org/10.1007/s13577-026-01347-7
Ask AI
Helpful
Bookmark
Share
View Full Paper